Airways symptoms, immunological response and exposure in powder painting.
OBJECTIVE
Powder painting is an alternative to solvent-based spray painting. Powder paints may contain organic acid anhydrides (OAAs), which are irritants to the airways and may cause sensitisation. The aim of this study was to determine the prevalence of respiratory symptoms and immunological response among powder painters and to describe the exposure to OAAs.


METHODS
In all, 205 subjects in 32 enterprises participated: 93 exposed and 26 formerly exposed workers in 25 powder paint shops and 86 unexposed workers. They completed a questionnaire about working conditions and symptoms and took part in a medical examination, which included a lung function test. Urine samples, for determination of two OAAs, and blood samples, for analysis of specific antibodies against the OAAs, were taken. In addition, 33 paint samples were analysed for nine OAAs.


RESULTS
The powder painters reported more work-related respiratory symptoms than unexposed subjects did. The prevalence of three or more symptoms was 24% in subjects with low exposure, 44% in highly exposed individuals, 46% in formerly exposed subjects and 19% in unexposed workers. Asthma symptoms were frequent, 7%, 40%, 15% and 2%, respectively. Regression analyses of the lung volumes did not show any influence of exposure. IgG, but not IgE, against the OAAs and metabolites of OAAs was found in some subjects, but no associations with the exposure could be observed. OAAs were found in only small amounts in the paint samples.


CONCLUSIONS
The exposure to organic acid anhydrides was estimated to be low, and yet, IgG antibodies to OAA were observed in some subjects. The prevalence of work-related symptoms from the eyes and the airways was relatively high among the powder painters, and these symptoms, but not the lung volumes, were clearly related to exposure. The symptoms were probably caused by irritative properties of the powder paint dust.
Blomqvist
Anna
A
Department of Occupational and Environmental Medicine, Central Hospital, Halmstad, Sweden.
Düzakin-Nystedt
Meltem
M
Ohlson
Carl-Göran
CG
Andersson
Lennart
L
Jönsson
Bo
B
Nielsen
Jörn
J
Welinder
Hans
H
D000328:Adult; D000336:Aerosols / Q000633:toxicity; D000368:Aged; D000812:Anhydrides / Q000097:blood / Q000276:immunology* / Q000652:urine; D004305:Dose-Response Relationship, Drug; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007074:Immunoglobulin G; D007221:Industry; D019570:Inhalation Exposure / Q000009:adverse effects* / Q000032:analysis; D008176:Lung Volume Measurements; D008875:Middle Aged; D016273:Occupational Exposure / Q000009:adverse effects* / Q000032:analysis; D010150:Paint / Q000633:toxicity*; D011208:Powders / Q000633:toxicity; D015995:Prevalence; D012044:Regression Analysis; D012130:Respiratory Hypersensitivity / Q000139:chemically induced* / Q000453:epidemiology / Q000276:immunology; D011795:Surveys and Questionnaires; D013548:Sweden / Q000453:epidemiology
D000336:Aerosols; D000812:Anhydrides; D007074:Immunoglobulin G; D011208:Powders
Allergy. 2003 Jan;58(1):46-52
12580806
Allergy. 1999 Jul;54(7):752-6
10442533
Occup Environ Med. 1999 Mar;56(3):202-5
10448330
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120
742764
J Chromatogr B Biomed Sci Appl. 1997 Apr 11;691(2):331-9
9174269
Toxicol Appl Pharmacol. 1995 Nov;135(1):156-62
7482535
Scand J Work Environ Health. 2001 Oct;27(5):327-34
11712613
Occup Environ Med. 1998 Oct;55(10 ):668-72
9930087
Clin Exp Allergy. 1997 May;27(5):510-4
9179424
Occup Environ Med. 1994 Jan;51(1):3-13
8124460
Int Arch Occup Environ Health. 1993;65(2):101-5
8253506
Eur Respir J. 1997 Apr;10 (4):948-51
9150339
J Allergy Clin Immunol. 1988 Jul;82(1):126-33
3392364
Occup Med (Lond). 1998 Oct;48(7):455-9
10024745
J Occup Med. 1982 Jun;24(6):473-9
6980265
Acta Med Scand. 1963 Feb;173:185-92
13970718
Br J Ind Med. 1989 Apr;46(4):222-32
2653411
Clin Exp Allergy. 1990 Nov;20(6):639-45
2083403
Eur Respir J. 1994 Mar;7(3):608-11
8013618